Market Cap 20.61M
Revenue (ttm) 570,000.00
Net Income (ttm) -26.43M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -4,636.84%
Debt to Equity Ratio 0.00
Volume 701,400
Avg Vol 374,038
Day's Range N/A - N/A
Shares Out 71.08M
Stochastic %K 97%
Beta 0.44
Analysts Strong Sell
Price Target $3.20

Latest News on OVID

Ovid Therapeutics Added to Russell 3000® Index

Jun 26, 2023, 8:00 AM EDT - 1 year ago

Ovid Therapeutics Added to Russell 3000® Index